AFP and neoplasm: miRNAs have also been reported as potential tumor biomarkers for being more efficient and better at diagnosing, stratifying, and monitoring in comparison with classic tumor biomarkers such as the previously mentioned AFP, LDH, and hCG, that have low sensitivity for the diagnosis and treatment of TGCT.